Premium
Ω‐3 Fatty Acid Supplements for Cancer‐Associated Weight Loss
Author(s) -
Jatoi Aminah
Publication year - 2005
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1177/0115426505020004394
Subject(s) - medicine , anorexia , weight loss , cancer , disease , fatty acid , body weight , intensive care medicine , obesity , biochemistry , chemistry
Ω‐3 fatty acids have been tested for the treatment of cancer anorexia/weight loss, a syndrome that predicts a poor prognosis among cancer patients with incurable disease. This review focuses on both the preclinical and clinical data of ω‐3 fatty acids for treating this syndrome. Overall, the promise of the former does not seem to be borne out completely in the latter. This review includes a discussion of how these data might be interpreted and explained to cancer patients who are striving to cope with this syndrome.